STSRX Mutual Fund

STSRX Mutual Fund

NAV$17.57
See how much of STSRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing the top 10 of 98 holdings · as of Aug 31, 2026
Top 10 weight
18.55%
STSRX top 10 holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
HALO
Halozyme Therapeutics IncHealth Care · Biotechnology
2.03%		2.0%102,264$10.89MHealth CareBiotechnology
2
LGND
Ligand Pharmaceuticals, Inc.Health Care · Biotechnology
1.99%		4.0%37,467$10.64MHealth CareBiotechnology
Sector and industry · Pro
3
RGEN
Repligen Corp
1.93%		5.9%57,263$10.36M
4—Firstcash Inc
1.91%		7.9%47,605$10.21M
5
XMTR
Xometry, Inc.
1.88%		9.7%108,435$10.05M
6
TVTX
Travere Therapeutics Inc
1.84%		11.6%148,988$9.87M
7
EZPW
Ezcorp, Inc. - Class A
1.77%		13.3%293,661$9.49M
8
MANH
Manhattan Associates Inc
1.76%		15.1%42,317$9.44M
9
TWST
Twist Bioscience Corp.
1.73%		16.8%66,773$9.28M
10—U.S. Government Money Market
1.71%		18.5%9,166,681$9.17M
More holdings · Pro
FundXLS Pro
See the other 88 holdings of STSRX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime
Themes in the top 10
BiotechnologyPharmaceuticalsLife Sciences ToolsBiotechnology ToolsLending & CreditPaymentsValue RetailConsumer SpendingManufacturingSupply ChainRobotics & AutomationInternet & DigitalData & AnalyticsImmunologyCloud Computing

STSRX Mutual Fund Top Holdings

STSRX holdings top 10 positions. The top 10 holdings account for 18.5% of the fund, led by Halozyme Therapeutics Inc at 2.0%, Ligand Pharmaceuticals, Inc. at 2.0%, Repligen Corp at 1.9%.

STSRX portfolio concentration is well-diversified, with the top 10 representing 18.5% of total assets. The largest sector exposure is Information Technology at 27.2%.

STSRX sectors provide a detailed breakdown. STSRX overlap shows how holdings compare to other funds in your portfolio.